The company previously expected FY Sales to be flat to low-single digit % growth.
BeautyHealth Expects Q3 Net Sales Of $70M – $80M (Est $100.6M), FY24 Of $325M – $345M (Est $393.74M)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.